A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota
Watson H, Mitra S, Croden FC, Taylor M, Wood HM, Perry SL, Spencer JA, Quirke P, Toogood GJ, Lawton CL, Dye L, Loadman PM, Hull MA
Gut · 355 citas
Etiquetas de revisión
Solo mecanismosDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Solo mecanismos
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- Medical Research Council
- Subvenciones
- Medical Research Council (MC_G1002465)
Según 1 financiador declarado.
Publicación
- Publicado
- 2017-09-26 · Gut · vol. 67 · número 11 · págs. 1974–1983
- Editorial
- BMJ
- Citado
- 510 citas · más que el 100% de estudios similares · 20.0× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 39 trabajos
- Acceso
- De pago
- Áreas de investigación
- Fatty Acid Research and Health · Gut microbiota and health · Colorectal Cancer Screening and Detection
- Palabras clave
- Eicosapentaenoic acid, Polyunsaturated fatty acid, Docosahexaenoic acid, Arachidonic acid, Bifidobacterium, Biology, Fatty acid, Microbiome, Omega 3 fatty acid, Lactobacillus, Food science, Biochemistry, Bioinformatics, Fermentation
- MeSH
- feces, humans, fatty acids, omega-3, fatty acids, chromatography, liquid, cross-over studies, polymerase chain reaction, dietary supplements, aged, middle aged, female, male, mass spectrometry, healthy volunteers, gastrointestinal microbiome
13 autores
- Henry Watson🇬🇧University of Leeds; St James's University Hospital
- Suparna Mitra🇬🇧Leeds General Infirmary; University of Leeds
- Fiona Croden🇬🇧University of Leeds
- Morag Taylor🇬🇧University of Leeds; St James's University Hospital
- Henry M. Wood🇬🇧University of Leeds; St James's University Hospital
- Sarah Perry🇬🇧University of Leeds; St James's University Hospital
- Jade A. Spencer🇬🇧University of Bradford
- Philip Quirke🇬🇧University of Leeds; St James's University Hospital
- Giles J. Toogood🇬🇧St James's University Hospital
- Clare Louise Lawton🇬🇧University of Leeds
- Louise Dye🇬🇧University of Leeds
- Paul M. Loadman🇬🇧University of Bradford
- Mark A. Hull🇬🇧 · autor de correspondenciaUniversity of Leeds; St James's University Hospital
Resumen
El texto original del estudio, en el idioma en que se publicó.
Objective
Omega-3 polyunsaturated fatty acids (PUFAs) have anticolorectal cancer (CRC) activity. The intestinal microbiota has been implicated in colorectal carcinogenesis. Dietary omega-3 PUFAs alter the mouse intestinal microbiome compatible with antineoplastic activity. Therefore, we investigated the effect of omega-3 PUFA supplements on the faecal microbiome in middle-aged, healthy volunteers (n=22).
Design
A randomised, open-label, cross-over trial of 8 weeks' treatment with 4 g mixed eicosapentaenoic acid/docosahexaenoic acid in two formulations (soft-gel capsules and Smartfish drinks), separated by a 12-week 'washout' period. Faecal samples were collected at five time-points for microbiome analysis by 16S ribosomal RNA PCR and Illumina MiSeq sequencing. Red blood cell (RBC) fatty acid analysis was performed by liquid chromatography tandem mass spectrometry.
Results
Both omega-3 PUFA formulations induced similar changes in RBC fatty acid content, except that drinks were associated with a larger, and more prolonged, decrease in omega-6 PUFA arachidonic acid than the capsule intervention (p=0.02). There were no significant changes in α or β diversity, or phyla composition, associated with omega-3 PUFA supplementation. However, a reversible increased abundance of several genera, including Bifidobacterium, Roseburia and Lactobacillus was observed with one or both omega-3 PUFA interventions. Microbiome changes did not correlate with RBC omega-3 PUFA incorporation or development of omega-3 PUFA-induced diarrhoea. There were no treatment order effects.
Conclusion
Omega-3 PUFA supplementation induces a reversible increase in several short-chain fatty acid-producing bacteria, independently of the method of administration. There is no simple relationship between the intestinal microbiome and systemic omega-3 PUFA exposure.
Trial registration number
ISRCTN18662143.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.